Skip to main content
OpenTrials
Completed

NCT Number: NCT01178957

Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) Metabolism During Acute Hyperglycemia

The purpose of this study is to estimate the acute effect of hyperglycemia on Very-Low-Density-Lipoprotein-triglyceride(VLDL-TG) secretion.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

Male

Study type

Observational

Primary location

Department of Endocrinology MEA, Aarhus Hospital

Aarhus C, 8000, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Type 1 diabetes
  • Age 18-50 years

Exclusion criteria

  • Smoking
  • Alcohol abuse
  • Use of medications (except insulin in diabetics)

Treatment and study plan

Hyperglycemia

Other

Hyperglycemia with a blood glucose of 15 mmol/L

Primary outcomes

  1. Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) secretion

    Time frame: 8 hours

    Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) kinetics over a single study day

Sponsors and collaborators

Lead sponsor

University of Aarhus

Other

Registry information

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Aug 10, 2010
Registry last updated
Aug 7, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.